Literature DB >> 17207538

Protein kinase C-zeta mediates retinal degeneration in response to TNF.

Hong Liang1, Christophe Baudouin, Francine Behar-Cohen, Patricia Crisanti, Boubaker Omri.   

Abstract

Tumor necrosis factor-alpha (TNF) has been implicated in retinal ganglion cells (RGC) degeneration in glaucoma. Atypical protein kinase C (PKC) zeta is involved in cell protection against various stresses. The aim of this study was to investigate the potential proapoptotic effects of intravitreal injections of TNF with or without PKCzeta specific inhibitor on the rat retina. TNF was injected in the vitreous of rat eyes alone or in combination with specific PKCzeta inhibitor. PKCzeta and NF-kappaB were studied by immunohistochemistry and western-blotting analysis on retina, and apoptosis quantified by the TUNEL assay. While low basal PKCzeta was observed in the control eyes, TNF induced intense expression of PKCzeta mostly in bipolar cells processes. PKCzeta staining became nuclear when TNF was coinjected with PKCzeta inhibitor. TNF alone did not induce apoptosis in the retina. Coinjection of the PKCzeta-specific inhibitor and TNF, however, induced apoptosis in the inner nuclear and ganglion cell layers. The PKCzeta-specific inhibitor unmasks retinal cells to TNF cytotoxicity showing a link between the proapoptotic effects of TNF and the antiapoptotic PKCzeta signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17207538     DOI: 10.1016/j.jneuroim.2006.11.028

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Network analysis of human glaucomatous optic nerve head astrocytes.

Authors:  Tatiana Nikolskaya; Yuri Nikolsky; Tatiana Serebryiskaya; Svetlana Zvereva; Eugene Sviridov; Zoltan Dezso; Eugene Rahkmatulin; Richard J Brennan; Nick Yankovsky; Sanjoy K Bhattacharya; Olga Agapova; M Rosario Hernandez; Valery I Shestopalov
Journal:  BMC Med Genomics       Date:  2009-05-09       Impact factor: 3.063

Review 2.  Gene therapy targeting glaucoma: where are we?

Authors:  Xuyang Liu; Carol A Rasmussen; B'ann T Gabelt; Curtis R Brandt; Paul L Kaufman
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

3.  Spinal TNF is necessary for inactivity-induced phrenic motor facilitation.

Authors:  Oleg Broytman; Nathan A Baertsch; Tracy L Baker-Herman
Journal:  J Physiol       Date:  2013-07-22       Impact factor: 5.182

Review 4.  The hidden side of SERPINB1/Leukocyte Elastase Inhibitor.

Authors:  Alicia Torriglia; Elisabeth Martin; Imene Jaadane
Journal:  Semin Cell Dev Biol       Date:  2016-07-12       Impact factor: 7.727

Review 5.  Glaucomatous neurodegeneration: an eye on tumor necrosis factor-alpha.

Authors:  Renu Agarwal; Puneet Agarwal
Journal:  Indian J Ophthalmol       Date:  2012-07       Impact factor: 1.848

6.  The activation of the atypical PKC zeta in light-induced retinal degeneration and its involvement in L-DNase II control.

Authors:  Imene Jaadane; Sabine Chahory; Chloé Leprêtre; Boubaker Omri; Laurent Jonet; Francine Behar-Cohen; Patricia Crisanti; Alicia Torriglia
Journal:  J Cell Mol Med       Date:  2015-03-17       Impact factor: 5.310

7.  PKCζ mediates breakdown of outer blood-retinal barriers in diabetic retinopathy.

Authors:  Samy Omri; Francine Behar-Cohen; Pierre-Raphaël Rothschild; Emmanuelle Gélizé; Laurent Jonet; Jean Claude Jeanny; Boubaker Omri; Patricia Crisanti
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

8.  PKCζ as a promising therapeutic target for TNFα-induced inflammatory disorders in chronic cutaneous wounds.

Authors:  Jian Zhang; Xuekang Yang; Hongtao Wang; Bin Zhao; Xue Wu; Linlin Su; Songtao Xie; Yunchuan Wang; Jun Li; Jiaqi Liu; Mengdong Liu; Fu Han; Ting He; Wei Zhang; Ke Tao; Dahai Hu
Journal:  Int J Mol Med       Date:  2017-09-20       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.